about
T cell responses to human endogenous retroviruses in HIV-1 infectionHuman endogenous retrovirus K106 (HERV-K106) was infectious after the emergence of anatomically modern humansHTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complicationsCross-sectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiensTregs control the development of symptomatic West Nile virus infection in humans and miceStrong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removalAssociation of differentiation state of CD4+ T cells and disease progression in HIV-1 perinatally infected childrenInfluence of HAART on alternative reading frame immune responses over the course of HIV-1 infectionPsoriasis patients are enriched for genetic variants that protect against HIV-1 diseaseAge-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected childrenSequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts.Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotranspositionThe frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesisImmunity to HIV-1 is influenced by continued natural exposure to exogenous virus.A decreased frequency of regulatory T cells in patients with common variable immunodeficiencyRapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruptionA comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in malesImmune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection.Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.Inhibition of human immunodeficiency virus type 1 gp120 presentation to CD4 T cells by antibodies specific for the CD4 binding domain of gp120Immunodominance of HIV-1 specific CD8+ T-cell responses is related to disease progression rate in vertically infected adolescents.A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties.Cutting edge: An antibody recognizing ancestral endogenous virus glycoproteins mediates antibody-dependent cellular cytotoxicity on HIV-1-infected cells.IL-2 immunotherapy to recently HIV-1 infected adults maintains the numbers of IL-17 expressing CD4+ T (T(H)17) cells in the periphery.Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID)Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasisDynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo.CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.Residual viral replication during antiretroviral therapy boosts human immunodeficiency virus type 1-specific CD8+ T-cell responses in subjects treated early after infection.Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection.Associations between antibodies to a panel of Plasmodium falciparum specific antigens and response to sub-optimal antimalarial therapy in Kampala, Uganda.Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasisNK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionVariability of HIV-1 genomes among children and adolescents from São Paulo, BrazilT lymphocyte responses against human parvovirus B19: small virus, big response.
P50
Q21559508-AFC9EC57-BFD4-463C-884C-CDF13F7FAE31Q21560816-45382847-59E4-4C8C-AE31-D7AA74AFA3EDQ24607794-A2716328-C806-4715-A189-4C04903963F8Q24654497-B868C1BD-4FD6-41DA-A496-D5EA1BA49B33Q27490259-9EA4874F-9C45-4D9F-BD1F-84DC8318C134Q28469094-F95D5DAB-98F6-4666-80AB-E54787C9C4BFQ28478811-C44781B6-8D88-42FE-8D0F-34A8EEFE92E1Q28480902-F8CCB8C0-DC7E-4472-9E62-A3DDCE0FAFE6Q28483308-B71A6651-2D2C-4888-AC40-BF4244BE5C11Q28483967-62785B55-3893-4784-9A4C-FD94ACB8DA9CQ33274640-D31346EE-D1C8-4411-A54B-1C4851AD7ADAQ33303686-C41A36D8-38DE-4A5A-A15B-80DB07302E26Q33318459-D79B1F30-9AEE-4514-9BCB-CBACCFACBE6DQ33355836-F04E8404-0C14-407C-88CD-E224C125E3D8Q33379075-4E3FD561-1DD7-4F4F-8691-C26BBA65D059Q33489543-3561A1AB-D9B1-4205-B130-FABA425F44FDQ33565727-378A462C-34C9-421E-9A77-BF36CD94535DQ33745356-3F29C34C-B077-40D4-A783-0ED21034648AQ33748552-DFBA9981-6AE7-427D-82DB-7536EABBAF73Q33772422-D424B6AF-D44E-4E0B-A839-DA517B713342Q33773625-6611BD95-2CB6-49EB-9D58-624FF7A9F5B3Q33782527-D22DCB9E-9829-4C98-9B83-2CE04915C5B2Q33786292-8167BB04-77EA-4E0D-837E-0D5D80821E0DQ33849085-9D44EFFC-CA1B-45AF-BC2C-7E1762CE91F4Q33982883-29FE8496-09A1-43D9-B026-8DA04AB777A7Q33985800-C5FE5966-8EEB-4E10-B424-B5463FA7A5D7Q33998437-8C6B524C-3889-4BA2-B46B-A67275E01F42Q34112781-0BD37667-1EE1-4D43-86F8-3D358E88642EQ34115373-9FCF9C79-8BA7-426C-95AB-1E40A2CDA3EAQ34240041-CFD2757E-24D8-426E-8694-461BA11DEA09Q34261911-C663AA46-CAFD-4392-8958-91574BF1FB06Q34310907-9B51AF83-70E9-4637-B9AD-0590EDAF0DFFQ34326482-D500A014-F329-46B8-8C96-8CFD2B835E1CQ34342894-0D2A2286-83B7-4204-806F-310EA11A4729Q34534163-28D56707-8562-40E9-8ED5-708254E98F86Q34587031-12DE996E-48CB-4A7A-8AA3-DE5D0A76BB07Q34611308-54C54517-5B19-4D94-B70C-0DCD21D8BC8EQ34680046-25CF1815-8B72-48E3-A9DF-CE0CF9EFAD21Q34717313-425A605F-AC6A-4177-9E10-6F37F9A4C375Q34737826-ED4E8DBB-00B6-48B0-B3B5-621EF024CFD4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Douglas F. Nixon
@ast
Douglas F. Nixon
@en
Douglas F. Nixon
@es
Douglas F. Nixon
@nl
Douglas F. Nixon
@sl
type
label
Douglas F. Nixon
@ast
Douglas F. Nixon
@en
Douglas F. Nixon
@es
Douglas F. Nixon
@nl
Douglas F. Nixon
@sl
altLabel
Douglas F. Nixon
@en
prefLabel
Douglas F. Nixon
@ast
Douglas F. Nixon
@en
Douglas F. Nixon
@es
Douglas F. Nixon
@nl
Douglas F. Nixon
@sl
P106
P1153
36979049200
7101658985
P21
P31
P496
0000-0002-2801-1786